Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Macaca mulatta | 11 | 2020 | 3716 | 1.17 | Why? |
| Disease Models, Animal | 19 | 2021 | 10998 | 1.16 | Why? |
| Henipavirus Infections | 4 | 2020 | 122 | 1.10 | Why? |
| Nipah Virus | 4 | 2020 | 121 | 1.05 | Why? |
| Disease Reservoirs | 4 | 2019 | 1672 | 0.87 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 13 | 2020 | 8843 | 0.84 | Why? |
| Plasmodium yoelii | 1 | 2018 | 9 | 0.79 | Why? |
| Virus Replication | 16 | 2021 | 14331 | 0.76 | Why? |
| Hemorrhagic Fever, Ebola | 3 | 2018 | 1475 | 0.74 | Why? |
| Vesiculovirus | 1 | 2018 | 153 | 0.70 | Why? |
| Communicable Diseases, Emerging | 4 | 2018 | 2523 | 0.68 | Why? |
| Ebola Vaccines | 1 | 2018 | 126 | 0.66 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.56 | Why? |
| Hantavirus | 1 | 2014 | 63 | 0.55 | Why? |
| Respiration Disorders | 1 | 2020 | 526 | 0.54 | Why? |
| Camelus | 5 | 2019 | 1425 | 0.53 | Why? |
| Callithrix | 5 | 2018 | 288 | 0.51 | Why? |
| Zoonoses | 3 | 2020 | 3034 | 0.48 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.48 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.48 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.47 | Why? |
| Animals | 38 | 2021 | 78931 | 0.46 | Why? |
| Lung | 15 | 2021 | 31049 | 0.45 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.42 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.41 | Why? |
| Mesocricetus | 2 | 2020 | 1847 | 0.38 | Why? |
| Malaria | 1 | 2018 | 1097 | 0.37 | Why? |
| Bronchoalveolar Lavage Fluid | 4 | 2021 | 2309 | 0.37 | Why? |
| Coronavirus Infections | 29 | 2020 | 253789 | 0.35 | Why? |
| Viral Load | 12 | 2021 | 15850 | 0.34 | Why? |
| Swine Diseases | 1 | 2017 | 1219 | 0.34 | Why? |
| Virus Shedding | 8 | 2020 | 5834 | 0.33 | Why? |
| Viral Vaccines | 4 | 2020 | 7560 | 0.29 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2018 | 2984 | 0.26 | Why? |
| Coronavirus | 7 | 2014 | 18339 | 0.26 | Why? |
| Host Specificity | 2 | 2017 | 926 | 0.24 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2016 | 12361 | 0.22 | Why? |
| Dipeptidyl Peptidase 4 | 4 | 2016 | 1061 | 0.21 | Why? |
| Keratin-18 | 1 | 2021 | 114 | 0.21 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.21 | Why? |
| Mediastinum | 1 | 2021 | 122 | 0.20 | Why? |
| Antibodies, Monoclonal | 2 | 2018 | 8041 | 0.20 | Why? |
| Pneumonia, Viral | 15 | 2020 | 243684 | 0.19 | Why? |
| Drug Evaluation, Preclinical | 3 | 2020 | 3347 | 0.19 | Why? |
| Cricetinae | 5 | 2021 | 3344 | 0.19 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.18 | Why? |
| Antigens, Viral | 1 | 2015 | 6298 | 0.18 | Why? |
| Hendra Virus | 1 | 2017 | 31 | 0.18 | Why? |
| Swine | 2 | 2017 | 3352 | 0.18 | Why? |
| Common Variable Immunodeficiency | 1 | 2020 | 195 | 0.18 | Why? |
| Cytokines | 3 | 2020 | 15010 | 0.17 | Why? |
| DNA Mutational Analysis | 1 | 2020 | 581 | 0.17 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.17 | Why? |
| Respiratory Tract Infections | 3 | 2020 | 6817 | 0.16 | Why? |
| Antiviral Agents | 6 | 2021 | 41703 | 0.16 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.16 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.16 | Why? |
| Radiography | 3 | 2020 | 1576 | 0.16 | Why? |
| Tissue Distribution | 1 | 2018 | 483 | 0.16 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.16 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.15 | Why? |
| Ferrets | 2 | 2020 | 1201 | 0.15 | Why? |
| Body Fluids | 1 | 2020 | 451 | 0.15 | Why? |
| Ribavirin | 2 | 2013 | 1182 | 0.15 | Why? |
| Horses | 1 | 2017 | 474 | 0.15 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.15 | Why? |
| Rabbits | 2 | 2016 | 1171 | 0.15 | Why? |
| Fomites | 1 | 2021 | 709 | 0.15 | Why? |
| Secondary Prevention | 1 | 2020 | 762 | 0.14 | Why? |
| Interferon-alpha | 2 | 2013 | 1442 | 0.14 | Why? |
| Transcription, Genetic | 1 | 2021 | 1326 | 0.14 | Why? |
| Hantavirus Infections | 1 | 2014 | 62 | 0.14 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.13 | Why? |
| Lymph Nodes | 1 | 2021 | 1060 | 0.13 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.13 | Why? |
| Environment | 2 | 2019 | 769 | 0.13 | Why? |
| Drug Resistance, Viral | 1 | 2020 | 1083 | 0.13 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 877 | 0.12 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Equipment Reuse | 1 | 2020 | 985 | 0.12 | Why? |
| Immunohistochemistry | 3 | 2017 | 2275 | 0.12 | Why? |
| Social Stigma | 1 | 2021 | 1049 | 0.12 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.12 | Why? |
| Macrophages | 2 | 2021 | 2784 | 0.12 | Why? |
| Macrophages, Alveolar | 1 | 2015 | 668 | 0.11 | Why? |
| Microscopy, Electron, Transmission | 1 | 2013 | 605 | 0.11 | Why? |
| Mice | 6 | 2021 | 21357 | 0.11 | Why? |
| Decontamination | 1 | 2020 | 1196 | 0.11 | Why? |
| Receptors, Opioid, delta | 1 | 2009 | 2 | 0.10 | Why? |
| Receptors, Opioid, kappa | 1 | 2009 | 7 | 0.10 | Why? |
| DNA, Viral | 1 | 2021 | 2521 | 0.10 | Why? |
| Opioid Peptides | 1 | 2009 | 10 | 0.10 | Why? |
| Receptors, Opioid | 1 | 2009 | 25 | 0.10 | Why? |
| Receptors, Opioid, mu | 1 | 2009 | 23 | 0.10 | Why? |
| Respiratory Tract Diseases | 1 | 2018 | 1061 | 0.10 | Why? |
| Species Specificity | 1 | 2013 | 1356 | 0.10 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.10 | Why? |
| Humans | 31 | 2021 | 930598 | 0.10 | Why? |
| Binding, Competitive | 1 | 2009 | 264 | 0.09 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.09 | Why? |
| Virulence | 1 | 2015 | 2172 | 0.09 | Why? |
| Antibodies, Neutralizing | 3 | 2019 | 25288 | 0.09 | Why? |
| Male | 16 | 2021 | 367725 | 0.09 | Why? |
| Host-Pathogen Interactions | 3 | 2020 | 11041 | 0.09 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.09 | Why? |
| Pandemics | 13 | 2020 | 389249 | 0.09 | Why? |
| Syndrome | 1 | 2013 | 1310 | 0.09 | Why? |
| Body Temperature | 1 | 2013 | 875 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.09 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.09 | Why? |
| Primates | 2 | 2020 | 584 | 0.08 | Why? |
| Body Weight | 1 | 2013 | 1074 | 0.08 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Female | 15 | 2021 | 380317 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Immune Evasion | 1 | 2016 | 2081 | 0.08 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.07 | Why? |
| Chiroptera | 2 | 2017 | 3530 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Virion | 1 | 2013 | 1444 | 0.07 | Why? |
| Influenza in Birds | 1 | 2010 | 528 | 0.07 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Health Behavior | 1 | 2021 | 4449 | 0.06 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.06 | Why? |
| Bacterial Load | 1 | 2021 | 179 | 0.05 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.05 | Why? |
| Immunization, Passive | 1 | 2017 | 10067 | 0.05 | Why? |
| Cyclin-Dependent Kinases | 1 | 2020 | 124 | 0.05 | Why? |
| Casein Kinase II | 1 | 2020 | 120 | 0.05 | Why? |
| Half-Life | 1 | 2020 | 298 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.05 | Why? |
| Africa, Central | 1 | 2018 | 29 | 0.05 | Why? |
| Factor Analysis, Statistical | 1 | 2021 | 538 | 0.05 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 230 | 0.05 | Why? |
| Neutrophils | 1 | 2015 | 5476 | 0.05 | Why? |
| Population Growth | 1 | 2018 | 37 | 0.05 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 243 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| National Institutes of Health (U.S.) | 1 | 2021 | 443 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 347 | 0.04 | Why? |
| Proto-Oncogene Proteins | 1 | 2020 | 340 | 0.04 | Why? |
| Influenza A virus | 1 | 2010 | 2234 | 0.04 | Why? |
| Urbanization | 1 | 2018 | 133 | 0.04 | Why? |
| Camelids, New World | 1 | 2019 | 276 | 0.04 | Why? |
| Travel | 1 | 2016 | 7220 | 0.04 | Why? |
| Africa, Western | 1 | 2018 | 363 | 0.04 | Why? |
| Promoter Regions, Genetic | 1 | 2021 | 823 | 0.04 | Why? |
| Phosphorylation | 1 | 2020 | 1060 | 0.04 | Why? |
| Respiratory System | 2 | 2021 | 3213 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Monkey Diseases | 1 | 2017 | 190 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Sheep, Domestic | 1 | 2014 | 18 | 0.04 | Why? |
| Self Efficacy | 1 | 2021 | 717 | 0.04 | Why? |
| Immunity, Humoral | 2 | 2020 | 4849 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2020 | 37182 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Adenoviridae | 1 | 2020 | 1151 | 0.03 | Why? |
| A549 Cells | 1 | 2020 | 2066 | 0.03 | Why? |
| Cross Infection | 1 | 2016 | 8675 | 0.03 | Why? |
| Netherlands | 2 | 2021 | 3533 | 0.03 | Why? |
| Goats | 1 | 2014 | 217 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.03 | Why? |
| Health Care Costs | 1 | 2021 | 1007 | 0.03 | Why? |
| Twins, Monozygotic | 1 | 1993 | 83 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Apolipoproteins E | 1 | 1993 | 170 | 0.03 | Why? |
| Animals, Wild | 1 | 2019 | 1028 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.03 | Why? |
| Patient Compliance | 1 | 2021 | 1468 | 0.03 | Why? |
| Microbiota | 1 | 2021 | 1240 | 0.03 | Why? |
| Immunity, Innate | 2 | 2021 | 6570 | 0.03 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.03 | Why? |
| Bacteria | 1 | 2021 | 1897 | 0.03 | Why? |
| Radioligand Assay | 1 | 2009 | 7 | 0.03 | Why? |
| Tritium | 1 | 2009 | 17 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Codon, Nonsense | 1 | 2009 | 66 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Brain Chemistry | 1 | 2009 | 49 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Organ Culture Techniques | 1 | 2009 | 119 | 0.02 | Why? |
| Alternative Splicing | 1 | 2009 | 82 | 0.02 | Why? |
| Emotions | 1 | 2021 | 2418 | 0.02 | Why? |
| Gene Knockout Techniques | 1 | 2009 | 347 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2014 | 3198 | 0.02 | Why? |
| Cell Line | 2 | 2017 | 12040 | 0.02 | Why? |
| Molecular Epidemiology | 1 | 2014 | 1638 | 0.02 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
| Mucous Membrane | 1 | 2010 | 305 | 0.02 | Why? |
| Rats, Wistar | 1 | 2009 | 621 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
| Birds | 1 | 2010 | 412 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Viral Tropism | 1 | 2014 | 1329 | 0.02 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2010 | 492 | 0.02 | Why? |
| Lipids | 1 | 1993 | 1079 | 0.02 | Why? |
| Fear | 1 | 2021 | 3607 | 0.02 | Why? |
| Cluster Analysis | 1 | 2014 | 3001 | 0.02 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2010 | 572 | 0.02 | Why? |
| Influenza, Human | 1 | 2010 | 10779 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2014 | 2830 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 11367 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Saudi Arabia | 1 | 2014 | 4423 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2013 | 3786 | 0.02 | Why? |
| Drug Combinations | 1 | 2013 | 3852 | 0.02 | Why? |
| Dogs | 1 | 2010 | 2529 | 0.01 | Why? |
| Rats | 1 | 2009 | 2764 | 0.01 | Why? |
| Analgesics, Opioid | 1 | 2009 | 1070 | 0.01 | Why? |
| Receptors, Virus | 1 | 2016 | 5659 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 8811 | 0.01 | Why? |
| RNA, Viral | 2 | 2018 | 32276 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Seasons | 1 | 2010 | 4071 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Phylogeny | 1 | 2014 | 13341 | 0.01 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Brain | 1 | 2009 | 5133 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Analysis of Variance | 1 | 1993 | 950 | 0.01 | Why? |
| Gene Frequency | 1 | 1993 | 1210 | 0.01 | Why? |
| Alleles | 1 | 1993 | 1557 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.00 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |
| Phenotype | 1 | 1993 | 4037 | 0.00 | Why? |
| Genetic Variation | 1 | 1993 | 3919 | 0.00 | Why? |
| Cohort Studies | 1 | 1993 | 36005 | 0.00 | Why? |